Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management

Dewkoemar Ramsoekh*, Anja Wagner, Monique E. van Leerdam, Dennis Dooijes, Carli M.J. Tops, Ewout W. Steyerberg, Ernst J. Kuipers

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

64 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases

Medicine and Dentistry